Met Life Investment Management, LLC Revolution Medicines, Inc. Transaction History

Met Life Investment Management, LLC

  • $16.5 Billion
  • Q2 2025

A detailed history of Met Life Investment Management, LLC transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 2,887 shares of RVMD stock, worth $131,935. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,887
Previous 98,886 97.08%
Holding current value
$131,935
Previous $3.5 Million 96.97%
% of portfolio
0.0%
Previous 0.02%

Shares

40 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025
SELL
$31.13 - $41.98 $2.99 Million - $4.03 Million
-95,999 Reduced 97.08%
2,887 $106,000
Q1 2025

May 14, 2025
SELL
$35.36 - $44.42 $51,024 - $64,098
-1,443 Reduced 1.44%
98,886 $3.5 Million
Q4 2024

Feb 13, 2025
BUY
$42.97 - $60.6 $598,056 - $843,430
13,918 Added 16.11%
100,329 $4.39 Million
Q3 2024

Nov 13, 2024
SELL
$36.92 - $47.94 $55,416 - $71,957
-1,501 Reduced 1.71%
86,411 $3.92 Million
Q2 2024

Aug 13, 2024
BUY
$30.14 - $40.68 $503,488 - $679,559
16,705 Added 23.46%
87,912 $3.41 Million
Q1 2024

May 14, 2024
BUY
$26.56 - $33.55 $1.89 Million - $2.39 Million
71,207 New
71,207 $2.3 Million
Q4 2023

Feb 14, 2024
BUY
$18.35 - $34.12 $402,525 - $748,456
21,936 Added 41.03%
75,397 $2.16 Million
Q3 2023

May 09, 2024
BUY
$25.17 - $35.05 $198,465 - $276,369
7,885 Added 17.3%
53,461 $1.48 Million
Q2 2023

Apr 29, 2024
BUY
$20.28 - $27.0 $1.08 Million - $1.44 Million
53,461 New
53,461 $1.43 Million
Q2 2023

Aug 10, 2023
BUY
$20.28 - $27.0 $159,907 - $212,895
7,885 Added 17.3%
53,461 $1.43 Million
Q1 2023

May 09, 2024
BUY
$20.76 - $30.09 $946,157 - $1.37 Million
45,576 New
45,576 $987 Million
Q1 2023

May 15, 2023
BUY
$20.76 - $30.09 $125,784 - $182,315
6,059 Added 15.33%
45,576 $987,000
Q4 2022

Jun 14, 2023
SELL
$17.68 - $25.53 $107,123 - $154,686
-6,059 Reduced 13.29%
39,517 $941,000
Q3 2022

May 10, 2024
BUY
$17.46 - $26.0 $91,857 - $136,786
5,261 Added 15.36%
39,517 $779,000
Q3 2022

Jun 14, 2023
SELL
$17.46 - $26.0 $105,790 - $157,534
-6,059 Reduced 13.29%
39,517 $779,000
Q3 2022

Mar 22, 2023
BUY
$17.46 - $26.0 $91,857 - $136,786
5,261 Added 15.36%
39,517 $779,000
Q3 2022

Nov 14, 2022
BUY
$17.46 - $26.0 $91,857 - $136,786
5,261 Added 15.36%
39,517 $779,000
Q2 2022

Jun 20, 2023
SELL
$14.54 - $27.17 $164,592 - $307,564
-11,320 Reduced 24.84%
34,256 $667,000
Q1 2022

May 10, 2024
BUY
$17.31 - $26.4 $592,971 - $904,358
34,256 New
34,256 $873,000
Q1 2022

Jun 20, 2023
SELL
$17.31 - $26.4 $195,949 - $298,848
-11,320 Reduced 24.84%
34,256 $873,000
Q1 2022

Mar 22, 2023
BUY
$17.31 - $26.4 $218,850 - $333,775
12,643 Added 58.5%
34,256 $873,000
Q1 2022

May 12, 2022
BUY
$17.31 - $26.4 $218,850 - $333,775
12,643 Added 58.5%
34,256 $874,000
Q4 2021

Jun 21, 2023
SELL
$24.35 - $33.7 $583,499 - $807,553
-23,963 Reduced 52.58%
21,613 $543,000
Q3 2021

Jun 21, 2023
SELL
$23.95 - $33.41 $573,913 - $800,603
-23,963 Reduced 52.58%
21,613 $594,000
Q2 2021

May 17, 2024
BUY
$29.0 - $47.44 $143,724 - $235,112
4,956 Added 29.75%
21,613 $685,000
Q2 2021

Jun 21, 2023
SELL
$29.0 - $47.44 $694,927 - $1.14 Million
-23,963 Reduced 52.58%
21,613 $685,000
Q2 2021

Mar 22, 2023
BUY
$29.0 - $47.44 $143,724 - $235,112
4,956 Added 29.75%
21,613 $685,000
Q2 2021

Aug 16, 2021
BUY
$29.0 - $47.44 $143,724 - $235,112
4,956 Added 29.75%
21,613 $686,000
Q1 2021

May 17, 2024
SELL
$37.21 - $54.43 $2.03 Million - $2.97 Million
-54,550 Reduced 76.61%
16,657 $764,000
Q1 2021

Jun 26, 2023
SELL
$37.21 - $54.43 $1.08 Million - $1.57 Million
-28,919 Reduced 63.45%
16,657 $764 Million
Q4 2020

Jun 22, 2023
SELL
$30.19 - $45.49 $873,064 - $1.32 Million
-28,919 Reduced 63.45%
16,657 $659,000
Q3 2020

May 24, 2024
BUY
$22.61 - $34.8 $218,073 - $335,646
9,645 Added 137.55%
16,657 $580 Million
Q3 2020

Jun 26, 2023
SELL
$22.61 - $34.8 $653,858 - $1.01 Million
-28,919 Reduced 63.45%
16,657 $579,000
Q3 2020

Mar 22, 2023
BUY
$22.61 - $34.8 $218,073 - $335,646
9,645 Added 137.55%
16,657 $579,000
Q3 2020

Nov 13, 2020
BUY
$22.61 - $34.8 $218,073 - $335,646
9,645 Added 137.55%
16,657 $580,000
Q2 2020

May 24, 2024
SELL
$19.65 - $39.34 $1.26 Million - $2.53 Million
-64,195 Reduced 90.15%
7,012 $221 Million
Q2 2020

Jun 26, 2023
SELL
$19.65 - $39.34 $757,782 - $1.52 Million
-38,564 Reduced 84.61%
7,012 $221,000
Q1 2020

Jul 12, 2023
SELL
$20.0 - $34.08 $771,280 - $1.31 Million
-38,564 Reduced 84.61%
7,012 $153,000
Q1 2020

Mar 22, 2023
SELL
$20.0 - $34.08 $650,100 - $1.11 Million
-32,505 Reduced 82.26%
7,012 $153,000
Q1 2020

May 15, 2020
BUY
$20.0 - $34.08 $140,240 - $238,968
7,012 New
7,012 $154,000

Others Institutions Holding RVMD

# of Institutions
332
Shares Held
195M
Call Options Held
908K
Put Options Held
723K
View Full List

About Revolution Medicines, Inc.

RVMD Quotes by TradingView
  • Ticker RVMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,697,600
  • Market Cap $4.01B
  • Description
  • Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...
More about RVMD
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email